1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Small Bone Innovations

Anonymous board for Small Bone Innovations


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    37
    Views:
    23,801
  2. Anonymous
    Replies:
    3
    Views:
    4,735
  3. Anonymous
    Replies:
    7
    Views:
    6,266
  4. Anonymous
    Replies:
    4
    Views:
    3,779
  5. Anonymous
    Replies:
    26
    Views:
    13,272
  6. Anonymous
    Replies:
    1
    Views:
    2,723
  7. Anonymous
    Replies:
    11
    Views:
    7,745
  8. Anonymous
    Replies:
    2
    Views:
    3,693
  9. Anonymous
    Replies:
    3
    Views:
    5,284
  10. Anonymous
    Replies:
    24
    Views:
    15,126
  11. Anonymous
    Replies:
    3
    Views:
    3,434
  12. Anonymous
    Replies:
    10
    Views:
    4,705
  13. Anonymous
    Replies:
    19
    Views:
    7,090
  14. Anonymous
    Replies:
    1
    Views:
    3,389
  15. Anonymous
    Replies:
    4
    Views:
    4,146
  16. Anonymous
    Replies:
    12
    Views:
    5,528
  17. Anonymous
    Replies:
    8
    Views:
    5,894
  18. Anonymous
    Replies:
    9
    Views:
    4,972
  19. Anonymous
    Replies:
    31
    Views:
    13,220
  20. Anonymous
    Replies:
    0
    Views:
    3,220

Thread Display Options

Loading...